Literature DB >> 15713384

(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.

Li-Qiang Sun1, Katherine Takaki, Jie Chen, Stephen Bertenshaw, Lawrence Iben, Cathy D Mahle, Elaine Ryan, Dedong Wu, Qi Gao, Cen Xu.   

Abstract

(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives (e.g., 3 and 4) were synthesized as novel melatoninergic ligands with significantly lower vasoconstrictive activity in vitro in the rat tail artery. Binding affinity assays were performed on cloned human MT1 and MT2 receptors stably expressed in NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713384     DOI: 10.1016/j.bmcl.2005.01.015

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.

Authors:  Céline Legros; Ulrich Matthey; Teresa Grelak; Sandrine Pedragona-Moreau; Werner Hassler; Saïd Yous; Emmanuel Thomas; Franck Suzenet; Benoît Folleas; François Lefoulon; Pascal Berthelot; Daniel-Henri Caignard; Gérald Guillaumet; Philippe Delagrange; Jean-Louis Brayer; Olivier Nosjean; Jean A Boutin
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.